Home The Journal npj Schizophrenia Publishes the Results of the PRISMA-3 Study of the Efficacy and Safety of Doria® in Schizophrenic Patients

The Journal npj Schizophrenia Publishes the Results of the PRISMA-3 Study of the Efficacy and Safety of Doria® in Schizophrenic Patients

Find out more …

General Information
of the Company
Financial and
Economic Information
Corporate Governance
Information for Investors
Contact
Read time: 0 mins
The Journal npj Schizophrenia Publishes the Results of the PRISMA-3 Study of the Efficacy and Safety of Doria® in Schizophrenic Patients
https://www.rovi.es/sites/default/files/Publicaci%C3%B3n%20en%20npj%20schizophrenia_PR_0.pdf
Year: 
2020